Philip Dormitzer in

Philip Dormitzer

Login to view DISC.
President and Chief Scientific Officer at Biological E Limited
📍 India

Philip Dormitzer is the President and Chief Scientific Officer for R&D at Biological E Limited and a Professor at Dalhousie University. His distinguished career includes leadership roles at Pfizer and GSK, where he was instrumental in developing groundbreaking vaccines. He earned his MD and a PhD in Cancer Biology from Stanford University.

He is a passionate advocate for public health, focusing on immunization and raising awareness about preventable diseases like RSV and bacterial meningitis. He has also expressed interest in relational mindfulness and embodied leadership as tools for high-functioning professionals to restore their capacity and well-being.

Unique fact: He played a pivotal leadership role in the development of Comirnaty, the worlds first COVID-19 vaccine, as well as Abrysvo, an RSV vaccine.

Read the full overview →
Experience
32 Years
Current Role
President and Chief Scientific Officer
Job Level
Leadership
Location
India
Personality Overview

How Philip shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Philip cares about

Vaccine R&D
Led the development of the world's first COVID-19 vaccine (Comirnaty) and an RSV vaccine (Abrysvo) at Pfizer, and now leads R&D at Biological E Limited.
Global Health Equity
His work focuses on building a more resilient vaccine system and expanding global access to vaccines and biologics, particularly for low and middle-income countries.
+4 more topics Login to view topics
Career

Work history

4-2026
President and Chief Scientific Officer
Biological E Limited
4-2026
Professor, Department of Medicine, Faculty of Medicine
Dalhousie University
2025
Founder and President
Dormitzer Biologics Inc and Dormitzer Biologics LLC
12-2021 - 12-2024
Senior Vice President and Global Head of Vaccines R&D and Infectious Disease Research
GSK
9-2015 - 12-2021
Vice President and Chief Scientific Officer: RNA and Viral Vaccines
Pfizer Vaccines Research and Development
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1986 - 1994
MD
Stanford University School of Medicine
1987 - 1992
PhD
Stanford University, Program in Cancer Biology
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Biological E Limited Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Philip. Free, 10 seconds.